IP Library Granted Patent US 6,849,262
Granted Patent B2
US 6,849,262 · App. 10/067,331 · Granted Feb 1, 2005

Vascular coating composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,849,262
App. No.
10/067,331
Granted
Feb 1, 2005
Kind
B2
Abstract

This invention relates to methods of coating the lumenal surface of a blood vessel, or other tissue cavity, and to compositions suitable for use in same.

Claims (38)

1. A method of inhibiting restenosis following vascular intervention comprising applying to a site of vascular injury resulting from said intervention a first composition comprising about 27-53% by weight of a water soluble globular protein and a second composition comprising about 5-15% by weight of a di- or polyaldehyde, wherein said di- or polyaldehyde is present in a weight ratio of one part by weight to every 20-60 parts by weight of said globular protein, and allowing said composition to cure so that a coating is produced at said site of vascular injury that inhibits restenosis.

2. The method according to claim 1 wherein said intervention is angioplasty.

3. The method according to claim 1 wherein said globular protein is albumin or hemoglobulin.

4. The method according to claim 3 wherein said globular protein is bovine albumin.

5. The method according to claim 1 wherein said aldehyde is glutaraldehyde.

6. The method according to claim 1 wherein said globular protein is bovine albumin and said aldehyde is glutaraldehyde.

7. The method according to claim 1 wherein said coating further comprising a therapeutic agent.

8. The method according to claim 7 wherein said therapeutic agent is selected from the group consisting of an anti-thrombotic agent, a thrombolytic agent, a vasodilating agent, a growth modulating factor and an antibiotic.

9. A method of providing structural support to a surface of a hollow or tubular organ comprising:

i) coating said surface with a first composition comprising about 27-53% by weight of a water soluble proteinaceous material and with a second composition comprising about 5-15% by weight of a di- or polyaldehyde, wherein said di- or polyaldehyde is present in said coating in a weight ratio of one part by weight to every 20-60 parts by weight of said proteinaceous material, and

ii) allowing the product of step (i) to cure so that said structural support is provided.

10. The method according to claim 9 wherein said proteinaceous material a globular protein.

11. The method according to claim 9 wherein said proteinaceous material is albumin or hemoglobin.

12. The method according to claim 9 wherein said aldehyde is glutaraldehyde.

13. The method according to claim 9 wherein said proteinaceous material is bovine albumin and said aldehyde is glutaraldehyde.

14. The method according to claim 9 wherein said surface is selected from the group consisting of the surface of a vein, artery ureter, urethrae, bronchi, biliary duct, pancreatic duct, gut, eye, nasal passage, sinus, capsular joint, esophagus, lymphatic system, trachea, spermatic tube and fallopian tube.

15. The method according to claim 9 wherein said surface is coated with said second composition and then with said first composition.

16. A method of occluding a tissue lumen comprising:

i) introducing into said lumen a first composition comprising about 27-53% by weight of a water soluble proteinaceous material and a second composition comprising about 5-15% by weight of a di- or polyaldehyde, wherein said di- or polyaldehyde is present in a weight ratio of one part by weight to every 20-60 parts by weight of said proteinaceous material, and

ii) allowing the product of step (i) to cure so that said lumen is occluded.

17. The method according to claim 16 wherein said proteinaceous material a globular protein.

18. The method according to claim 16 wherein said proteinaceous material is albumin or hemoglobin.

19. The method according to claim 16 wherein said aldehyde is glutaraldehyde.

20. The method according to claim 16 wherein said proteinaceous material is bovine albumin and said aldehyde is glutaraldehyde.

21. The method according to claim 16 wherein said second composition is introduced into said lumen prior to said first composition.

22. A composition comprising a support and cells adhered thereto, wherein said support is produced by a method comprising:

i) contacting a first composition comprising about 27-53% by weight of a water soluble proteinaceous material and with a second composition comprising about 5-15% by weight of a di- or polyaldehyde, wherein said di- or polyaldehyde is present in a weight ratio of one part by weight to every 20-60 parts by weight of said proteinaceous material, and

ii) allowing the product of step (i) to cure so that said support is thereby produced.

23. The method according to claim 22 wherein said proteinaceous material a globular protein.

24. The method according to claim 22 wherein said proteinaceous material is albumin or hemoglobin.

25. The method according to claim 22 wherein said aldehyde is glutaraldehyde.

26. The method according to claim 22 wherein said proteinaceous material is bovine albumin and said aldehyde is glutaraldehyde.

27. A method of providing structural support to a surface of a hollow or tubular organ comprising:

i) applying to said surface a coating comprising a water soluble proteinaceous material and a di- or polyaldehyde, wherein said di- or polyaldehyde is present in said coating in a weight ratio of one part by weight to every 20-60 parts by weight of said proteinaceous material, and

ii) allowing the coating of step (i) to cure so that said structural support is provided.

28. The method according to claim 27 wherein said proteinaceous material a globular protein.

29. The method according to claim 27 wherein said proteinaceous material is albumin or hemoglobin.

30. The method according to claim 27 wherein said aldehyde is glutaraldehyde.

Assignments (3)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →